BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2010
View Archived Issues
DEN1-80E and DEN-80E dengue virus vaccines show promise
Read More
MenACWY-CRM produces robust immunogenicity in infants
Read More
Exenatide is beneficial in patients with nonalcoholic steatohepatitis
Read More
Astex's AT-9283 enters phase II trial in multiple myeloma
Read More
Novartis discontinues clinical program for anticancer candidate ASA-404
Read More
Bionovo receives FDA approval for clinical development plan for Menerba
Read More
Eisai reports developments of first half fiscal year 2010
Read More
NCX-429 has anti-inflammatory activity in several preclinical models
Read More
Cell surface glycoprotein MUC18 is a marker for malignant pleural mesothelioma
Read More
Repros Therapeutics reports on type B meeting with FDA regarding Androxal
Read More
Clavis Pharma and Clovis Oncology sign additional agreement for CP-4126
Read More
FDA approves Egrifta for lipodystrophy in HIV-infected patients
Read More
AstraZeneca describes new GSK-3 inhibitors
Read More
First patient treated in phase IIb AP-214 trial
Read More
Hygeia Therapeutics completes preclinical studies of HYG-102
Read More
Choongwae Pharma claims new reverse-turn mimetics for treatment of AML
Read More
Novel mTOR inhibitors presented by Merck & Co.
Read More
Banyu Pharma claims new bile acid GPBA receptor agonists
Read More
Canadian scientists identify new antimitotic agents
Read More
FDA clears PolyMedix's IND application for PMX-30063
Read More
CytRx begins pharmacokinetic bafetinib trial in patients with brain cancer
Read More
EMA committee recommends orphan drug status for ThermoDox in primary liver cancer
Read More
Centocor Ortho Biotech submits sBLA to FDA to expand Simponi label
Read More
Aeras Global TB Vaccine Foundation receives additional grant from Dutch government
Read More
Sangamo BioSciences receives U.S. government grants for four programs
Read More
